Literature DB >> 19095668

Effect of ghrelin on gonadotrophin secretion in women during the menstrual cycle.

Christina I Messini1, Konstantinos Dafopoulos, Nektarios Chalvatzas, Panagiotis Georgoulias, Ioannis E Messinis.   

Abstract

BACKGROUND: It has been suggested that ghrelin may affect reproduction in animals by decreasing pituitary LH secretion. The role of ghrelin on LH secretion in women has not been investigated. Our aim was to assess the effect of ghrelin administration on basal and GnRH-induced LH secretion during the menstrual cycle.
METHODS: Normally cycling women (n = 10) received on Day 3 of three consecutive cycles a single bolus i.v. of either ghrelin (1 microg/kg, cycle 1) or GnRH (100 microg, cycle 2) or GnRH plus ghrelin (cycle 3). In cycle 1, ghrelin was also injected in late follicular and mid-luteal phase of the cycle. Saline was injected in a preceding cycle (cycle 1, control). Blood samples were taken before drugs or saline injection (time 0) as well as at -15, 15, 30, 45, 60, 75, 90 and 120 min.
RESULTS: Plasma ghrelin levels increased rapidly, peaking at 15 or 30 min (P < 0.001), then decreased steadily, approaching pre-injection levels at 120 min. Serum FSH, LH, estradiol and progesterone levels remained unchanged. The stimulating effect of GnRH on LH and FSH secretion was unaffected by ghrelin injection. In contrast to saline, ghrelin stimulated a significant increase in growth hormone levels.
CONCLUSIONS: Under these experimental conditions, our results demonstrate for the first time the inability of a bolus of ghrelin to affect basal and GnRH-induced LH and FSH secretion. It is suggested that ghrelin does not play a major physiological role in gonadotrophin secretion in women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095668     DOI: 10.1093/humrep/den458

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Effect of ghrelin and metoclopramide on prolactin secretion in normal women.

Authors:  C I Messini; K Dafopoulos; N Chalvatzas; P Georgoulias; G Anifandis; I E Messinis
Journal:  J Endocrinol Invest       Date:  2010-06-04       Impact factor: 4.256

2.  Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome.

Authors:  Margaret C Garin; Samantha F Butts; David B Sarwer; Kelly C Allison; Suneeta Senapati; Anuja Dokras
Journal:  Endocrine       Date:  2016-12-21       Impact factor: 3.633

3.  Pituitary immunoexpression of ghrelin in anorexia nervosa.

Authors:  Fabio Rotondo; Bernd W Scheithauer; Luis V Syro; Angelo Rotondo; Kalman Kovacs
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

Review 4.  Current and potential roles of ghrelin in clinical practice.

Authors:  G Angelidis; V Valotassiou; P Georgoulias
Journal:  J Endocrinol Invest       Date:  2010-12       Impact factor: 4.256

Review 5.  Clinical review: The human experience with ghrelin administration.

Authors:  Margaret C Garin; Carrie M Burns; Shailja Kaul; Anne R Cappola
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

6.  Ghrelin in female and male reproduction.

Authors:  Joëlle Dupont; Virginie Maillard; Stéphanie Coyral-Castel; Christelle Ramé; Pascal Froment
Journal:  Int J Pept       Date:  2010-03-14

7.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.